ALLMedicine™ Mitral Regurgitation Center

Feb 4th, 2023 - Mitral regurgitation may occur when hypertension causes left ventricular (LV) and left atrial (LA) remodeling. However, its role in LA function in hypertensive patients remains unclear. To explore how mitral regurgitation affects LA function in hy...

Feb 4th, 2023 - Patients with mitral regurgitation (MR) present with considerable heterogeneity in cardiac damage depending on underlying aetiology, disease progression, and comorbidities. This study aims to capture their cardiopulmonary complexity by employing a...

Feb 4th, 2023 - Mitral regurgitation is a serious complication of post-myocardial infarction, with increasing mortality. Surgery as the primary treatment carries a high risk. MitraClip is a new therapeutic to treat post-myocardial infarction mitral regurgitation....

Feb 2nd, 2023 - Mitral valve transcatheter edge-to-edge repair is safe and effective in treating degenerative mitral regurgitation (DMR) patients at prohibitive surgical risk, but outcomes in complex mitral valve anatomy patients vary. The PASCAL IID registry ass...

Feb 2nd, 2023 - Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation With Complex Mitral Valve Anatomy.|2023|Joseph MS,Bach DS,|

Jun 7th, 2022 - Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular hypertrophy in the absence of other potentially causative cardiac, systemic, syndromic, or metabolic diseases. Symptoms can be related to a range of pathophysiologic ...

Feb 19th, 2020 - Mitral regurgitation (MR) is a complex valve lesion that can pose significant management challenges. This expert consensus decision pathway emphasizes that recognition of MR should prompt an assessment of its etiology, mechanism, and severity, as ...

Feb 10th, 2020 - In this update, we focus on selected topics of high clinical relevance for health care providers who treat patients with heart failure (HF), on the basis of clinical trials published after 2017. Our objective was to review the evidence, and provid...

Feb 18th, 2014 - Transcatheter therapies for mitral regurgitation: a professional society overview from the American College of Cardiology, The American Association for Thoracic Surgery, Society for Cardiovascular Angiography and Interventions Foundation, and The ...

Sep 12th, 2013 - The interventional treatment of mitral valve regurgitation by the MitraClip procedure has grown rapidly in Germany and Europe during the past years. The MitraClip procedure has the potential to treat high-risk patients with secondary mitral valve ...

Feb 2nd, 2023 - With the aging population, the incidence and prevalence of VHD are increasing in the U.S. and other parts of the developed world. Despite the availability of effective therapies and procedures to treat VHD, many patients remain (1) untreated due t...

Jan 27th, 2023 - Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.

Jan 27th, 2023 - Prospective, single-arm, multi-center, interventional, pre-market trial

Jan 26th, 2023 - This study is designed as a prospective, observational, crossover study to assess the feasibility of using differences in invasive hemodynamics of cardiac function, representing myocardial reserve, to predict clinical outcomes for heart failure pa...

Jan 25th, 2023 - The objective of the study is to demonstrate the non-inferiority for clinical efficacy of an endovascular treatment strategy with the MitraClip® in comparison with a surgical treatment strategy in patients with severe primary mitral regurgitation ...

Feb 6th, 2023 - The population undergoing mitral valve surgery has changed significantly, without a reduction in case volumes, since the arrival of transcatheter edge-to-edge repair (TEER) as a minimally invasive alternative. Nationwide, there was a downtrend in ...

Oct 4th, 2022 - FDA advised that generic lots of atenolol and clopidogrel (Plavix) are under recall due to a label mix-up by manufacturer Golden State Medical Supply. LivaNova's LifeSPARC advanced circulatory support system has its controller component under clas...

Oct 3rd, 2022 - Among the benefits of fully optimized medical therapy in heart failure with reduced ejection fraction (HFrEF) may be, indirectly, lessened severity of associated mitral regurgitation (MR) that might render invasive mitral valve (MV) repair unneces...

Sep 20th, 2022 - Approximately 6 months after COVID vaccine-related myocarditis, follow-up MRI scans suggest some recovery in left ventricular ejection fraction and decline in late gadolinium enhancement. (JACC: Cardiovascular Imaging) Around the world, diet quali...

Sep 19th, 2022 - The design improvements introduced in the fourth-generation device for transcatheter mitral valve repair, called the MitraClip G4 (Abbott), appears to yield better outcomes than previous iterations, according to a multinational postapproval study.